Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ATROMID-S

CLOFIBRATE

Standard Dose
500MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview ATROMID-S is listed in Drugs@FDA under application 016099 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient CLOFIBRATE Form and strength CAPSULE;ORAL - 500MG Sponsor WYETH AYERST Submission history Latest submission status date: 1998-07-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview ATROMID-S is listed in Drugs@FDA under application 016099 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient CLOFIBRATE Form and strength CAPSULE;ORAL - 500MG Sponsor WYETH AYERST Submission history Latest submission status date: 1998-07-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.